Chemoinformaics analysis of beta-Hydroxypropiovanillone
Molecular Weight | 196.202 | nRot | 4 |
Heavy Atom Molecular Weight | 184.106 | nRig | 7 |
Exact Molecular Weight | 196.074 | nRing | 1 |
Solubility: LogS | -1.371 | nHRing | 0 |
Solubility: LogP | 0.571 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
nHA | 4 | APOL | 27.9095 |
nHD | 2 | BPOL | 14.6425 |
QED | 0.704 |
Synth | 1.908 |
Natural Product Likeliness | 0.699 |
NR-PPAR-gamma | 0.008 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.002 |
Pgp-sub | 0.008 |
HIA | 0.022 |
CACO-2 | -4.457 |
MDCK | 0.0000143 |
BBB | 0.736 |
PPB | 0.36284 |
VDSS | 0.947 |
FU | 0.651778 |
CYP1A2-inh | 0.415 |
CYP1A2-sub | 0.756 |
CYP2c19-inh | 0.05 |
CYP2c19-sub | 0.097 |
CYP2c9-inh | 0.032 |
CYP2c9-sub | 0.633 |
CYP2d6-inh | 0.017 |
CYP2d6-sub | 0.488 |
CYP3a4-inh | 0.036 |
CYP3a4-sub | 0.251 |
CL | 10.052 |
T12 | 0.917 |
hERG | 0.027 |
Ames | 0.118 |
ROA | 0.035 |
SkinSen | 0.238 |
Carcinogencity | 0.218 |
EI | 0.964 |
Respiratory | 0.123 |
NR-Aromatase | 0.05 |
Antiviral | No |
Prediction | 0.864142 |